Your browser doesn't support javascript.
loading
Consensus-based standards for best supportive care in clinical trials in advanced cancer.
Zafar, S Yousuf; Currow, David C; Cherny, Nathan; Strasser, Florian; Fowler, Robin; Abernethy, Amy P.
Afiliación
  • Zafar SY; Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. yousuf.zafar@duke.edu
Lancet Oncol ; 13(2): e77-82, 2012 Feb.
Article en En | MEDLINE | ID: mdl-22300862
Best supportive care is poorly defined in clinical trials, and a standard framework for delivery of such care is needed, using best available evidence and allowing replication of studies. We convened a panel of 36 experts to develop consensus statements via the Delphi method. The first round included open-ended questions; subsequent rounds sought to develop consensus-based standards. Consensus was assessed by use of a 5-point Likert agreement scale; more than 70% of panellists had to give a score of 5 to meet a-priori levels of consensus. The panel identified four key domains of best supportive care in clinical trials: multidisciplinary care; supportive care documentation; symptom assessment; and symptom management. Consensus was reached on 11 statements within these four domains. For example, 24 (96%) panellists recommended that the intervals between symptom assessments should be identical for control and experimental groups. Availability of resources was cited as a challenge to implementation of best supportive care standards.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cuidados Paliativos / Ensayos Clínicos como Asunto / Técnica Delphi / Neoplasias Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Cuidados Paliativos / Ensayos Clínicos como Asunto / Técnica Delphi / Neoplasias Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2012 Tipo del documento: Article País de afiliación: Estados Unidos